Venous, Arterial, and Arterialized‐Venous Blood Ammonia Levels and Their Relationship to Hepatic Encephalopathy after Propranolol

The American Journal of Gastroenterology

Volumn 83, Issue 3, 1988, Pages 249-255

  Snady, Harry ^a,b   Lieber, Charles S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

AMMONIA BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; PSYCHOMOTOR PERFORMANCE;

AMMONIA; ARTERIES; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; PROPRANOLOL; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; VEINS;

EID: 0023936802     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1988.tb02338.x     Document Type: Article

References (36)

1. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis
2. The effect of propranolol on portal hypertension in patients with cirrhosis: A hemodynamic study
3. Azygos blood flow and esophageal varices
4. Portal hypertension, propranolol
5. Risk of hepatic encephalopathy in patients taking propranolol for portal hypertension
6. Propranolol increases arterial ammonia in liver cirrhosis
7. Precipitation of hepatic encephalopathy by propranolol in cirrhosis
8. Hepatic encephalopathy
9. Hepatic encephalopathy
10. Ammonia and intermediary metabolism in hepatic coma: Value of the determination of blood ammonia in the diagnosis and management of cirrhosis
11. Effect of alteration in blood pH on distribution of ammonia from blood to cerebrospinal fluid in patients in hepatic coma
12. Methods for assessing hepatic encephalopathy
13. Suhclinical hepatic encephalopathy: Detection, prevalence, and relationship to nitrogen metabolism
14. The prevalence of subclinical hepatic encephalopathy in apparently healthy ambulant, non‐shunted patients with cirrhosis
15. 3 concentration
16. The present status of shunts for portal hypertension in cirrhosis
17. A kinetic determination of ammonia plasma
18. An evaluation of an ammonia method for the Du Pont Manual for ACA
19. Trial‐making and number‐connection tests in the assessment of mental state in portal systemic encephalopathy
20. Surgery and portal hypertension
21. Prognostic value of Child‐Turcotte criteria in medically treated cirrhosis
22. Propranolol in portal hypertension
23. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis
24. Traitement des hemorragies dues a l'hypertension portale par le propranolol
25. Propranolol for esophageal varices cases
26. Propranolol in the prevention of variceal rebleeding: The deleterious influence of ascites and jaundice
27. Propranolol in decompensated alcoholic cirrhosis
28. Propranolol for portal hypertension
29. Assessment of β‐adrenergic blockade with propranolol in patients with cirrhosis
30. Prophylaxis of first variceal bleeding in cirrhotic patients by propranolol: Final report of a multicenter randomized study
31. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension
32. Selective and non‐selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension
33. Influence of propranolol on weight and salt and water homoeostasis in chronic liver disease
34. Effects of propranolol on portal hemodynamics in patients with chronic liver disease